Sfoglia per RIVISTA
BLOOD
Collezione ASL Torino 4

  

Items : 9

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. in Blood / Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.

2022
ASL Torino 4
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Visco C; Dreyling M; Seymour JF; Stefani PM; Sciarra R; Chiappella A; Vitagliano O; Sartori R; Mannina D; Morello L; Nicoli P; Arcari A; Angelillo P; Williams ME; Marin-Niebla A; Cencini E; van Meerten T; Mocikova H; Duglosz-Danecka M; Auer RL; Pagani C; Bernard S; Infante G; Iadecola S; Crucitti L; Muzi C; Klener P; Giné E; Tucker D; et alii...

Mortality in ?-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. in Blood / Blood. 2022 Mar 31;139(13):2080-2083. doi: 10.1182/blood.2021014862.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Cappellini MD; Piga A; Merella P; Tartaglione I; Miceli R; Casale M; Longo F; Pasanisi A; Casu G; Barella S; Origa R; Giuditta M; Graziadei G; Derchi G; Musallam KM; Pinto VM; Gianesin B; Forni GL;

Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. in Blood / Blood. 2022 Aug 25;140(8):900-908. doi: 10.1182/blood.2022015796.

2022
ASL Torino 4
ASL Torino 3

Vedovati MC; Gussoni G; Delrio P; Campanini M; Frasson S; Dentali F; Persiani R; Righini M; Martellucci J; Milone M; Castagnoli G; Portale G; Muratore A; Guerra F; De Luca R; De Prizio M; Visonà A; Chiari D; Boncompagni M; Avruscio G; Rondelli F; Donini A; Pirozzi F; Pace U; Becattini C; Agnelli G;

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS) in Blood

2022
ASL Biella
ASL Torino 4

Lanino L; Salutari P; Perego A; Fattizzo B; Riva M; Ubezio M; Musto P; Cilloni D; Oliva EN; Voso MT; Pelizzari AM; Poloni A; Capodanno I; Elena C; Fozza C; Pane F; Breccia M; De Gobbi M; Di Bassiano F; Barraco D; Crisà E; Ferrero D; Frairia C; Vaccarino A; Griguolo D; Paolini S; Quintini M; Sessa M; Turrini M; et alii...

Sparing anti-bacterial prophylaxis in acute myeloid leukemia during post induction aplasia does not impact on bacteriemiae incidence and early death: A retrospective single center study in Blood

2018
ASL Torino 4
AOU Città della Salute di Torino

Frairia C; Urbino I; Audisio E; Aydin S; D'Ardia S; Emanuela M; Iovino G; Nicolino B; Vitolo U;

Mantle cell lymphoma mimicking mucosa-associated lymphoid tissue (MALT) lymphomas: A pathological characterization (on behalf of the “fondazione italiana linfomi (FIL)-postgraduate master course”) in Blood

2017
ASL Torino 4

Rattotti S; Croci G; Morello L; Marino D; Carli G; Ferrero S; Loseto G; Olivieri J; Pelosini M; Sgherza N; Calimeri T; Giannoccaro M; Fama A; Mosna F; Tisi MC; Tomei G; Mazzone AM; Arcaini L; Zaja F; Paulli M;

Prognostic value of serum ferritin, transferrin saturation and C-reactive protein at diagnosis in myelodysplastic syndrome patients: Analysis of patients from the MDS piedmont registry in Blood

2011
ASL Torino 4
AOU Città della Salute di Torino

Messa E; Gioia D; Bertassello C; Ciccone G; Evangelista A; Manuela C; Allione B; Cilloni D; Salvi F; Cametti G; Lunghi M; Ferrero D; Falco P; Bonferroni M; Saglio G; Levis A;

Comparison among citology, histology, and flow cytometry in evaluating blast values in myelodysplatic syndromes (MDS). Survey from the Italian “Piemonte MDS registry” in Blood

2010
ASL Asti
ASL Torino 4
AO Cuneo

Levis A; Gioia DM; Godio L; Girotto M; Allione B; Bertassello C; Bonferroni M; Ciriello MM; Cametti G; Ciravegna G; Ferranti A; Lunghi M; Ferrero D; Freilone R; Gatto S; Salvi F; Savio M; Scaravaglio P; Stacchini A; Tonso A; Boccadoro M; Gaidano G; Gallamini A; Vitolo U; Saglio G;

A multicenter, open label study of oral lenalidomide and prednisone (RP) followed by oral lenalidomide melphalan and prednisone (MPR) and oral lenalidomide maintenance in newly diagnosed elderly multiple myeloma patients in Blood

2010
ASL Torino 4

Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Siez MLM; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M;